company background image
530477 logo

Vikram Thermo (India) BSE:530477 Stock Report

Last Price

₹152.30

Market Cap

₹4.8b

7D

9.2%

1Y

143.1%

Updated

28 Mar, 2024

Data

Company Financials

Vikram Thermo (India) Limited

BSE:530477 Stock Report

Market Cap: ₹4.8b

530477 Stock Overview

Vikram Thermo (India) Limited engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally.

530477 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends3/6

Vikram Thermo (India) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vikram Thermo (India)
Historical stock prices
Current Share Price₹152.30
52 Week High₹173.00
52 Week Low₹60.10
Beta0.11
1 Month Change5.03%
3 Month Change-3.02%
1 Year Change143.14%
3 Year Change354.08%
5 Year Change901.97%
Change since IPO25,283.33%

Recent News & Updates

Recent updates

Shareholder Returns

530477IN PharmaceuticalsIN Market
7D9.2%2.7%2.5%
1Y143.1%63.9%47.3%

Return vs Industry: 530477 exceeded the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: 530477 exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is 530477's price volatile compared to industry and market?
530477 volatility
530477 Average Weekly Movement4.8%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 530477 has not had significant price volatility in the past 3 months.

Volatility Over Time: 530477's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985138Dhirajlal Patelhttps://www.vikramthermo.com

Vikram Thermo (India) Limited engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally. The company offers pharmaceutical polymer products, such as DRUGCOAT, a methacrylic co-polymer-based pharma polymer used for enteric and protective coating, taste masking, and sustained release formulation; DRCOAT, a ready to use tablet coating system for enteric and film coating, moisture barrier, and specialty coating applications in the pharmaceutical industry; and diphenyl oxide used as perfumery stabilizer and for manufacturing heat transfer fluids. It also provides cosmetic polymers, including AQUAPOL polymer, an acrylic emulsion capable of suspending, stabilizing, thickening, and improving the appearance of high surfactant-based cleansing products.

Vikram Thermo (India) Limited Fundamentals Summary

How do Vikram Thermo (India)'s earnings and revenue compare to its market cap?
530477 fundamental statistics
Market cap₹4.78b
Earnings (TTM)₹243.56m
Revenue (TTM)₹1.25b

19.6x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530477 income statement (TTM)
Revenue₹1.25b
Cost of Revenue₹592.60m
Gross Profit₹659.59m
Other Expenses₹416.04m
Earnings₹243.56m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)7.77
Gross Margin52.68%
Net Profit Margin19.45%
Debt/Equity Ratio11.2%

How did 530477 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

7%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.